Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia
Marcio Scorsin(Lyon 1 Université), A Lessana(Centre Cardiologique du Nord), Nawwar Al Attar(Centre Cardiologique du Nord), Richard Raffoul(Assistance Publique – Hôpitaux de Paris), Betta Medini(Lyon 1 Université), Didier Payen(Délégation Paris 7), Patrick Nataf(Hôpital Bichat-Claude-Bernard), François Simoneau(Lyon 1 Université), J Maillet, Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Alain Ruffenach(Centre Cardiologique du Nord), Ramzi Ramadan(Loma Linda University Medical Center), Jacques Callebert(Inserm)
Cited by 25
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Sepsis in European intensive care units: Results of the SOAP study*
|Critical Care Medicine|2006|2.9k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k